The clinical use of low reactive level laser therapy (LLLT) has been reported in several aspects of bioactivation. This study reports an investigation into the possible application of LLLT for the treatment of male infertility. Four azoospermic and 16 oligospermic male patients were treated with a 6 mW HeNe12.5 mW pulsed GaAs diode laser with a dose of 1.3 i/cm2. Although no improvement was noted in the azoospermic subjects. the sperm count increased from 2 to 5 times in the oligospermic subjects. In addition, ejaculation of abnormal spermatozoa decreased in several subjects. Libido also increased in 15 of the 20 patients. From these findings it was concluded that LLLT offers a possible treatment for the oligospermic patient, particularly for the subfertile.
Introduction
Since the first reports of the use of low energy lasers to stimulate wound healing by Mester in 1971 (1) and in laser acupuncture by Plog, (2) the applications of low reactive level laser therapy (LLLT) have increased to cover many fields, including orthopaedics, pain attenuation, internal medicine, sports medicine, immunology, rheumatology and dermatology. (4, 5) The literature reports that LLLT has a stimulative effect on cell replication, (6) but so far, no reports of experimental work on the use of LLLT in spermatogenesis for the treatment of infertility and subfertility have appeared. This study was designed to investigate this use of LLLT.
Materials and Methods
Twenty infertile males, of age range 25 -43, comprising four azoospermic subjects, nine severely oligospermic subjects (sperm count of less than 10,000,000/cc), and seven moderately oligospermic subjects (sperm count 10,000,000-30,000,000/cc) entered the study. All subjects had failed to respond to other treatment for at least 2 years, and had patent deferent ducts, with normal hormonal levels (LH, FSH, Prolactin, 12-ketosteroid and testosterone). Liver function was also normal.
A 6 mW continuous wave (c/w) helium neon (HeNe) laser (632.8 nm) mix with a 5-diode array of pulsed gallium arsenide (GaAs) infrared diodes (0.5 mW. 904 nm, 800 Hz) was used to irradiate the testicles with a dose per session of 1.3 J/cm 2 . Each testicle was irradiated for 4 min twice per week, for a total of 10 sessions. No other medication was administered during treatment, and a sperm count was taken before and after each irradiation session.
Results
The azoospermic patients showed no improvement at all in their sperm count after the treatment (Table 1 ). In the severely and moderately oligospermic subjects, however, a 2-to 5-fold increase in the sperm count was noted after LLLT irradiation (see Tables 2 and 3 ) with average increases of 3.6 and 2.7 fold in the severely and moderately oligospermic patients, respectively. In addition, some improvement in sperm quality was also observed (see Tables 4 and 5 ). Note also that the volume of ejaculate increased in 11 subjects, the number of active spermatozoa increased in 14 subjects, and there was a decrease in the volume of abnormal spermatozoa in 10 subjects. Fifteen of the patients, including two of the azoospermic subjects, reported a subjectively evaluated increase in libido following treatment. No adverse side effects were reported by any of the 20 subjects.
Discussion
Subcellular, cellular and systemic bioactivation following LLLT irradiation had been confirmed in most reports in the literature. (5) A significant increase in T3 and T4 cells was reported by Grandi et al. (6) following LLLT irradiation of the thyroid gland. The subjective reports of increased libido following LLLT for the treatment of infertility in this study support the findings of Celani et al, that the steroid production of Leydig cells can be stimulated by LLLT irradiation. (7) In this study, the azoospermic subjects showed no improvement in sperm count following LLLT. The oligospermic subjects all showed improvement, as reflected in the increased sperm count and improved sperm quality. However, the increased sperm count appeared on average to be almost proportional to the pre-LLLT irradiation count in both the severely and moderately oligospermic subjects. Accordingly, this treatment would be most effective on the moderately oligospermic patient, who could hope to achieve a normal sperm count following LLLT. Further studies are certainly necessary to elicit, examine and clarify the mechanisms and pathways involved, but from this preliminary report it would appear that LLLT offers a safe, noninvasive therapeutic modality for the moderately oligospermic subfertile subject. 
